title: Comparable pharmacokinetics of generic indinavir (Inhibisam) versus brand indinavir (Crixivan) when boosted with ritonavir.
authors.forename: Carlos
authors.initials: C
authors.lastname: Zala
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Alexander
authors.forename: Claudia
authors.initials: C
authors.lastname: Ochoa
authors.forename: Silvia
authors.initials: S
authors.lastname: Guillemi
authors.forename: Lillian S
authors.initials: LS
authors.lastname: Ting
authors.forename: Simon
authors.initials: S
authors.lastname: Bonner
authors.forename: Pedro
authors.initials: P
authors.lastname: Cahn
authors.forename: P Richard
authors.initials: PR
authors.lastname: Harrigan
authors.forename: Julio S G
authors.initials: JS
authors.lastname: Montaner
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016568:Drugs, Generic / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019469:Indinavir / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019438:Ritonavir / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D016568:Drugs, Generic; D019469:Indinavir; D019438:Ritonavir